Theratechnologies (Theratechnologies) Operating Cash Flow per Share : $-0.09 (TTM As of Feb. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Operating Cash Flow per Share?

Theratechnologies's operating cash flow per share for the three months ended in Feb. 2024 was $-0.04. Theratechnologies's operating cash flow per share for the trailing twelve months (TTM) ended in Feb. 2024 was $-0.09.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Theratechnologies's Operating Cash Flow per Share or its related term are showing as below:

THTX' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -80.9 Med: 1.6 Max: 46
Current: 31.5

During the past 13 years, Theratechnologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 46.00% per year. The lowest was -80.90% per year. And the median was 1.60% per year.

THTX's 3-Year OCF Growth Rate is ranked better than
80.81% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs THTX: 31.50

Theratechnologies Operating Cash Flow per Share Historical Data

The historical data trend for Theratechnologies's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Operating Cash Flow per Share Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.18

-0.70

-0.76

-0.62

-0.22

Theratechnologies Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.14	-0.15	0.22	-0.13	-0.04

Competitive Comparison of Theratechnologies's Operating Cash Flow per Share

For the Biotechnology subindustry, Theratechnologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theratechnologies's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theratechnologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Theratechnologies's Price-to-Operating-Cash-Flow falls into.

Theratechnologies Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Theratechnologies's Operating Cash Flow per Share for the fiscal year that ended in Nov. 2023 is calculated as

Operating Cash Flow per Share (A: Nov. 2023 )	=	Cash Flow from Operations (A: Nov. 2023 )	/	Shares Outstanding (Diluted Average) (A: Nov. 2023 )
	=	-5.678	/	26.332
	=	-0.22

Theratechnologies's Operating Cash Flow per Share for the quarter that ended in Nov. 2023 is calculated as

Operating Cash Flow per Share (Q: Feb. 2024 )	=	Cash Flow from Operations (Q: Feb. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Feb. 2024 )
	=	-1.708	/	49.362
	=	-0.03

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.09

Theratechnologies Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.